NM_025243.4(SLC19A3):c.771G>C (p.Val257=) AND Biotin-responsive basal ganglia disease
- Germline classification:
- Likely benign (1 submission)
- Last evaluated:
- Jul 22, 2023
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV003502338.1
Allele description
NM_025243.4(SLC19A3):c.771G>C (p.Val257=)
Condition(s)
- Name:
- Biotin-responsive basal ganglia disease (BBTGD)
- Synonyms:
- Biotin-thiamine-responsive basal ganglia disease; Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2); Thiamine metabolism dysfunction syndrome type 2; See all synonyms [MedGen]
- Identifiers:
- MONDO: MONDO:0011841; MedGen: C1843807; Orphanet: 199348; OMIM: 607483
Assertion and evidence details
Last Updated: Mar 5, 2024